Streetbeat News

Stock Prices

ARGX

DNTH

SNY

Wedbush initiated coverage on Dianthus Therapeutics Inc (DNTH) with an Outperform rating and a price target of $23, citing the potential of its lead program DNTH103, a monoclonal antibody targeting the complement C1s protein. DNTH103 is advancing in Phase 2 studies, with Phase 1 data showing a meaningful extension of half-life. The generalized myasthenia gravis (gMG) opportunity is highlighted as most attractive. The article also mentions Argenx SE (ARGX) and Sanofi SA (SNY) in the context of supporting the complement-inhibition approach in CIDP. The complement inhibition field is active with three acquisitions in the last three years, indicating a high interest in this therapeutic area. DNTH shares were up 1.14% at $11.50.

Portfolio Pulse from Vandana Singh

November 22, 2023 | 6:12 pm

BODY

Trading in shares of The Beachbody Company (BODY) has been halted. The reason for the halt has not been disclosed, leaving investors awaiting further details.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 6:12 pm

ADI

Analysts have mixed views on Analog Devices, Inc (NASDAQ:ADI) amid expectations of a cyclical recovery. Piper Sandler maintains a Neutral rating with a $175 price target, while Citi, BMO Capital, Goldman Sachs, Raymond James, Oppenheimer, and Susquehanna have positive outlooks with price targets ranging from $200 to $215. ADI reported mixed October quarter results and provided January guidance below expectations due to macro weakness, particularly in the industrial sector. Management expects inventory correction to last through the first half of 2024 but has cost-corrected to maintain a strong operating margin. Analysts project Q1 revenues and EPS with slight variations, anticipating a recovery in the second half of 2024. ADI shares saw a modest uptick of 0.84% to $182.77.

Portfolio Pulse from Anusuya Lahiri

November 22, 2023 | 6:05 pm

SPY

UNG

USO

The U.S. Baker Hughes Oil Rig Count remains unchanged from last week at 500, while the Gas Rig Count has increased by 3 from last week to 117.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 6:04 pm

USO

Oil prices dropped as OPEC+ postponed their 187th meeting, delaying decisions on supply adjustments. The meeting, originally scheduled for Nov. 25-26, is now set for Nov. 30. Crude oil futures fell 2.5% to $75.80, and the United States Oil Fund, LP ETF (USO) decreased by 2.3% to $70.78. The delay comes amid a 20% drop in oil prices since September due to supply and demand concerns and economic slowdown fears. The upcoming meeting will discuss supply limits into 2024, with Saudi Arabia's potential extension of a 1 million barrel-a-day curb being a focal point.

Portfolio Pulse from Surbhi Jain

November 22, 2023 | 6:02 pm

AMAT

BURL

CSCO

On CNBC's Halftime Report, analysts shared their final trades, which included Cisco Systems (CSCO), Burlington Stores (BURL), and Applied Materials (AMAT). Each company was highlighted as a potential investment opportunity, but specific details regarding the rationale behind each pick were not provided in the article.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 6:00 pm

GD

General Dynamics (NYSE:GD) has delivered an average annual return of 9.41% over the past 20 years, outperforming the market by 1.94% annually. A $1000 investment in GD 20 years ago would be worth $6,089.77 today. The company's current market capitalization stands at $67.20 billion.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 6:00 pm

CWK

Cushman & Wakefield (NYSE:CWK) received 4 analyst ratings in the last quarter, with 2 bullish and 2 indifferent. The average price target is $10.62, representing an implied upside from the current price of $8.42. This target has decreased by 17.55% from the previous target of $12.88. Analysts typically review stocks quarterly, and their ratings are based on company performance, financial statements, and insider communications.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 6:00 pm

CDW

CDW Corporation (NYSE:CDW) has seen a decrease in short interest, with the current level at 2.02 million shares or 1.72% of float, down 8.99% from the last report. It would take about 3.33 days to cover all short positions. While a decrease in short interest can indicate a more bullish sentiment, it does not necessarily predict a near-term rise in stock price. CDW's short interest is below its peer group average of 3.85%.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 6:00 pm

AME

Over the past 20 years, AMETEK (NYSE:AME) has produced an average annual return of 16.68%, outperforming the market by 9.21% annually. A $1000 investment in AME 20 years ago would be worth $22,147.99 today. The article highlights the impact of compounded returns on investment growth over time.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 6:00 pm